Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 6/20 | 0.49 |
| ▸ | DRD3 | P35462 | 6/20 | 0.49 |
| ▸ | DRD1 | P21728 | 5/20 | 0.49 |
| ▸ | DRD4 | P21917 | 5/20 | 0.49 |
| ▸ | DRD5 | P21918 | 5/20 | 0.49 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.42 |
| ▸ | HTR1D | P28221 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | BACE1 | P56817 | 1/20 | 0.39 |
| ▸ | ABL1 | P00519 | 2/20 | 0.39 |
| ▸ | ACMSD | Q8TDX5 | 2/20 | 0.38 |
| ▸ | STS | P08842 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3128608 | 0.86 | DRD2 (0.61) | DRD2DRD3DRD1DRD4DRD5 | |
| SCHEMBL9957718 | 0.84 | DRD2 (0.60) | DRD2DRD3DRD1DRD4DRD5 | |
| SCHEMBL15912455 | 0.84 | DRD2 (0.46) | DRD2DRD3DRD1DRD4DRD5 | |
| SCHEMBL10180323 | 0.84 | DRD2 (0.65) | DRD2DRD3DRD1DRD4DRD5 | |
| SCHEMBL3158316 | 0.83 | DRD2 (0.48) | DRD2DRD3DRD1DRD4DRD5 | |
| SCHEMBL3160924 | 0.83 | DRD2 (0.48) | DRD2DRD3DRD1DRD4DRD5 | |
| SCHEMBL10180668 | 0.82 | DRD2 (0.63) | DRD2DRD3DRD1DRD4DRD5 | |
| SCHEMBL7667692 | 0.81 | DRD2 (0.56) | DRD2DRD3DRD1DRD4DRD5 | |
| SCHEMBL4056753 | 0.80 | CA1 (0.51) | DRD2DRD3HSD11B1HTR1DCA1 | |
| SCHEMBL21332379 | 0.80 | DRD2 (0.47) | DRD2DRD3DRD1DRD4DRD5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210122978-A1 | Liquid Crystals Comprising Cyclopentane Groups | VVI BRIGHT CHINA LTD (CN) | 2021-04-29 | — | — | US | disclosed |
| US-10745617-B2 | Liquid crystals comprising cyclopentane groups | VVI BRIGHT CHINA LTD (CN) | 2020-08-18 | — | — | US | disclosed |
| US-20180163131-A1 | LIQUID CRYSTALS COMPRISING CYCLOPENTANE GROUPS | VVI BRIGHT, INC. | 2018-06-14 | — | — | US | disclosed |
| US-20180163131-A1 | LIQUID CRYSTALS COMPRISING CYCLOPENTANE GROUPS | VVI BRIGHT, INC. | 2018-06-14 | — | — | US | disclosed |
| US-9822303-B2 | Liquid crystals comprising cyclopentane groups | VVI BRIGHT CHINA LTD (CN) | 2017-11-21 | — | — | US | disclosed |
| US-9822303-B2 | Liquid crystals comprising cyclopentane groups | VVI BRIGHT CHINA LTD (CN) | 2017-11-21 | — | — | US | disclosed |
| US-9822303-B2 | Liquid crystals comprising cyclopentane groups | VVI BRIGHT CHINA LTD (CN) | 2017-11-21 | — | — | US | disclosed |
| US-20160237348-A1 | LIQUID CRYSTALS COMPRISING CYCLOPENTANE GROUPS | VVI BRIGHT, INC. | 2016-08-18 | — | — | US | disclosed |
| US-20160237348-A1 | LIQUID CRYSTALS COMPRISING CYCLOPENTANE GROUPS | VVI BRIGHT, INC. | 2016-08-18 | — | — | US | disclosed |
| US-20160237348-A1 | LIQUID CRYSTALS COMPRISING CYCLOPENTANE GROUPS | VVI BRIGHT, INC. | 2016-08-18 | — | — | US | disclosed |
| US-20150034872-A1 | LIQUID CRYSTALS COMPRISING CYCLOPENTANE GROUPS | VVI BRIGHT, INC. | 2015-02-05 | — | — | US | disclosed |
| US-20150034872-A1 | LIQUID CRYSTALS COMPRISING CYCLOPENTANE GROUPS | VVI BRIGHT, INC. | 2015-02-05 | — | — | US | disclosed |
| US-20150034872-A1 | LIQUID CRYSTALS COMPRISING CYCLOPENTANE GROUPS | VVI BRIGHT, INC. | 2015-02-05 | — | — | US | disclosed |
| US-8801966-B2 | Liquid crystals comprising cyclopentane groups | VVI BRIGHT CHINA LTD. (CN) | 2014-08-12 | — | — | US | disclosed |
| US-8801966-B2 | Liquid crystals comprising cyclopentane groups | VVI BRIGHT CHINA LTD. (CN) | 2014-08-12 | — | — | US | disclosed |
| US-8801966-B2 | Liquid crystals comprising cyclopentane groups | VVI BRIGHT CHINA LTD. (CN) | 2014-08-12 | — | — | US | disclosed |
| US-20110089374-A1 | Liquid Crystals Comprising Cyclopentane Groups | VVI BRIGHT, INC. (US) | 2011-04-21 | — | — | US | disclosed |
| US-20110089374-A1 | Liquid Crystals Comprising Cyclopentane Groups | VVI BRIGHT, INC. (US) | 2011-04-21 | — | — | US | disclosed |
| US-20110089374-A1 | Liquid Crystals Comprising Cyclopentane Groups | VVI BRIGHT, INC. (US) | 2011-04-21 | — | — | US | disclosed |
| WO-2009100204-A1 | LIQUID CRYSTALS COMPRISING CYCLOPENTANE GROUPS | VVI BRIGHT, INC. (US) | 2009-08-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150034872-A1 | LIQUID CRYSTALS COMPRISING CYCLOPENTANE GROUPS | CXCR5, CCL5, ELOC | DRD2 1293/4885DRD3 826/4885DRD1 1271/4885 |
| US-20210122978-A1 | Liquid Crystals Comprising Cyclopentane Groups | CXCR5, CCL5, ELOC | DRD2 1293/4885DRD3 826/4885DRD1 1271/4885 |
| US-10745617-B2 | Liquid crystals comprising cyclopentane groups | CXCR5, CCL5, ELOC | DRD2 1293/4885DRD3 826/4885DRD1 1271/4885 |
| US-20180163131-A1 | LIQUID CRYSTALS COMPRISING CYCLOPENTANE GROUPS | CXCR5, CCL5, ELOC | DRD2 1293/4885DRD3 826/4885DRD1 1271/4885 |
| US-20110089374-A1 | Liquid Crystals Comprising Cyclopentane Groups | CXCR5, CCL5, ELOC | DRD2 1293/4885DRD3 826/4885DRD1 1271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.